|
|
|
Indian Immunologicals Ltd |
|
|
Indian Immunologicals Ltd. (IIL) was founded by National Dairy Development Board (NDDB) in 1982 with the aim of providing foot and mouth disease (FMD) vaccines to the farmers at affordable prices. The technology for FMD vaccine production was imported from M/s.
Wellcome Foundation Limited, UK. In 2003, it invested Rs. 50 crore to set up an R&D facility in Hyderabad. IIL's manufacturing facility in Hyderabad has the capacity to produce 80 million trivalent doses of FMD vaccine. It has WHO-GMP and ISO-9001:2000 certified plant in Ooty for the production of veterinary vaccines. In 1989, IIL launched first tissue culture vaccine-Raksharab.
|
|
In 2006 it achieved sales turnover of Rs. 100 crores and became the 4th largest company in domestic animal healthcare market. It had launched Elovac-B, r-DNA Hepatitis-B vaccine, first vaccine from the Human Vaccine manufacturing Plant in Hyderabad. It exports products
to the Gulf, Asian and African markets. In 2006, it entered into collaboration with RxKinetix to develop thermostable vaccines with improved stability at non-refrigerated temperatures.
Its product portfolio in human vaccines includes MMR, DPT, Hepatitis B, Rabies and Measles whereas its veterinary vaccines include anti-rabies vaccine, canine vaccines, Foot and Mouth (FMD) vaccine, bacterial vaccine and various other combined vaccines.
Board of Directors
Dr. Amrita Patel, Chairman, IIL and NDDB
Mr. Deepak Tikku, Director, IIL and Managing Director of NDDB
Mr. K V Balasubramaniam, Managing Director, IIL
Prof. G. Padmanaban, Director, IIL
Mr. A M M Sarma, Director, IIL
Dr. V A Srinivasan, Director (Research)
Contact Address:
Indian Immunologicals Ltd.
Road # 44, Jubilee Hills
Hyderabad - 500033
Andhra Pradesh, India
Tel: +91 40 23544585
+91 40 23544593
+91 9948298322
+91 9948298422
Fax: +91 40 23544007
E-mail: info@indimmune.com
Website: www.indimmune.com
|
|
|
|
|
|
|
|
|
|
